Post by Bristol Myers Squibb

1,911,628 followers

Through our collaboration with Johnson & Johnson Innovative Medicine, we’re spotlighting the ongoing burden of thromboembolic diseases and the need for continued innovation. Learn more about our emerging research into factor XIa (FXIa) as a potential new target and what it could mean for patients: https://bit.ly/3Tq23BG #OneBMS #ISTH2026

Post content

Video Content